Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,176,731
+$2,158,724 QoQ
Shares Held
697,284
+101.4% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Dec 31, 2024CallValue
$70,473
CallShares
13,900
PutValue
$235,755
PutShares
46,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. ARDX ranks #47 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in ARDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,176,731 | 697,284 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,018,007 | 346,142 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,186,478 | 396,820 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $708,387 | 180,711 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $70,473 | 13,900 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $81,120 | 16,000 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $235,755 | 46,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $242,059 | 35,132 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,413,705 | 460,689 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $706,603 | 96,795 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,022,991 | 326,289 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,606,014 | 393,631 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $1,215,342 | 253,725 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $6,704 | 11,364 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $28,745 | 21,777 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $546,423 | 84,455 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $475,020 | 90,480 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $653,884 | 94,492 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $687,646 | 120,958 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||